An adjustable release rate linking strategy for cytotoxin–Peptide conjugates

https://doi.org/10.1016/S0960-894X(03)00016-7Get rights and content

Abstract

Peptide hormones are often rapidly internalized after binding to and activation of their receptors which are sometimes over-expressed on tumor cells. Thus, peptide ligands are increasingly being utilized for specific tumor cell targeting and internalization of radioactive isotopes for tumor imaging and for specifically delivering and internalizing cytotoxic moieties. Here, we describe a new carbamate linker system containing a series of built-in nucleophile assisted releasing (BINAR) groups which enable the ‘fine-tuning’ of intracellular cleavage rates of free cytotoxic agents containing reactive OH groups. Release rates were found to fit well with the chemical model and several conjugates of camptothecin and one of combretastatin were shown to have potent cytotoxic effects on cultures of human neuroblastoma IMR-32 cells which over-express somatostatin receptors.

References (15)

  • R.E Weiner et al.

    Semin. Nucl. Med.

    (2001)
  • L Sun et al.

    Peptides

    (2002)
  • K.T Hansen et al.

    J. Pharm. Sci.

    (1991)
  • L.F Liu et al.

    Ann. N.Y. Acad. Sci.

    (2000)
  • G.R Pettit et al.

    Can. J. Chem.

    (1982)
  • K Raynor et al.

    Mol. Pharmacol.

    (1993)
  • A.V Schally et al.

    Eur. J. Endocrinol.

    (1999)
    A Plonowski et al.

    Int. J. Oncol.

    (2002)
    M Langer et al.

    J. Med. Chem.

    (2002)
    C.M Huang et al.

    Chem Biol.

    (2000)
    W Arap et al.

    Curr. Opin. Oncol.

    (1998)
There are more references available in the full text version of this article.

Cited by (30)

  • Site-specific construction of triptolide-based antibody-drug conjugates

    2021, Bioorganic and Medicinal Chemistry
    Citation Excerpt :

    The carbamate linkage was formed between the linker and triptolide, due to carbamates group are generally supposed to be more stable than carbonates (L1-TL). Also, N,N'-Dimethyl-1,2-ethanediamine spacer was introduced to the linker, as it might improve the stability and the biological profile of the linker-drug (L2-TL).23–24 Additionally, the diamine spacer also provides a site to incorporate a branching PEGylated linker (L3-TL).

  • Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach

    2021, Bioorganic Chemistry
    Citation Excerpt :

    Ester and carbamate bonds can be hydrolyzed enzymatically after internalization by the acidic pH in the lysosomes or by the enzymes such as esterases and cytochrome P450 [155,180–182]. Carbamate linkers of varying stability have been used to connect the tumor-targeting peptide SST with the toxophore camptothecin (CPT) [155]. Alsarraf et al. has developed β-galactosidase-responsive SMDC consisting of phenolic and aniline self-immolative connectors, galactoside trigger, folic acid as ligand targeting and two MMAE molecules based around a chemical amplifier that delivers two drug molecules the potent antineoplastic drug monomethylauristatin E (MMAE) to cancer cells through a single internalization and activation pathway [183].

View all citing articles on Scopus
View full text